- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Earnings estimates for these five stocks improved a lot this year -- and the technical charts also say buy.
Here are Monday's top research calls, including downgrades for Bristol-Myers Squibb, JPMorgan and Weyerhaeuser, and an upgrade for Merck.
Jim Cramer says this merger of beverage can makers is a travesty that should have never been approved because it is going to cost consumers.